Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1991 Aug;214(2):149–154. doi: 10.1097/00000658-199108000-00009

Lovastatin inhibits gallstone formation in the cholesterol-fed prairie dog.

K D Saunders 1, J A Cates 1, M Z Abedin 1, S Rege 1, S F Festekdjian 1, W Howard 1, J J Roslyn 1
PMCID: PMC1358514  PMID: 1867522

Abstract

The efficacy of lovastatin, an inhibitor of hepatic cholesterol synthesis in the prevention of cholesterol gallstone formation, was evaluated in the prairie dog model. Two groups of animals were maintained on either nonlithogenic or 1.2% cholesterol-enriched chow for 21 days. Seven of the animals in each group received lovastatin, and the remaining six received only distilled water. All of the cholesterol-fed/water-treated animals had crystals and 83% had gallstones, but none of the cholesterol-fed/lovastatin-treated animals had gallstones and only three had microscopic crystals. These data indicate that lovastatin inhibits cholesterol gallstone formation in a diet-induced model of gallstone disease.

Full text

PDF
149

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Admirand W. H., Small D. M. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest. 1968 May;47(5):1043–1052. doi: 10.1172/JCI105794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Angelin B., Ewerth S., Einarsson K. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels. J Lipid Res. 1983 Apr;24(4):461–468. [PubMed] [Google Scholar]
  3. Brenneman D. E., Connor W. E., Forker E. L., DenBesten L. The formation of abnormal bile and cholesterol gallstones from dietary cholesterol in the prairie dog. J Clin Invest. 1972 Jun;51(6):1495–1503. doi: 10.1172/JCI106946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carey M. C. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res. 1978 Nov;19(8):945–955. [PubMed] [Google Scholar]
  5. Connerty H. V., Briggs A. R. Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol. 1966 Mar;45(3):290–296. doi: 10.1093/ajcp/45.3.290. [DOI] [PubMed] [Google Scholar]
  6. DRYER R. L., TAMMES A. R., ROUTH J. I. The determination of phosphorus and phosphatase with N-phenyl-p-phenylenediamine. J Biol Chem. 1957 Mar;225(1):177–183. [PubMed] [Google Scholar]
  7. DenBesten L., Safaie-Shirazi S., Connor W. E., Bell S. Early changes in bile composition and gallstone formation induced by a high cholesterol diet in prairie dogs. Gastroenterology. 1974 May;66(5):1036–1045. [PubMed] [Google Scholar]
  8. Duane W. C., Hunninghake D. B., Freeman M. L., Pooler P. A., Schlasner L. A., Gebhard R. L. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology. 1988 Sep-Oct;8(5):1147–1150. doi: 10.1002/hep.1840080531. [DOI] [PubMed] [Google Scholar]
  9. Gurll N., DenBesten L. Animal models of human cholesterol gallstone disease: a review. Lab Anim Sci. 1978 Aug;28(4):428–432. [PubMed] [Google Scholar]
  10. Havel R. J., Hunninghake D. B., Illingworth D. R., Lees R. S., Stein E. A., Tobert J. A., Bacon S. R., Bolognese J. A., Frost P. H., Lamkin G. E. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Ann Intern Med. 1987 Nov;107(5):609–615. doi: 10.7326/0003-4819-107-5-609. [DOI] [PubMed] [Google Scholar]
  11. Heberer G., Paumgartner G., Sauerbruch T., Sackmann M., Krämling H. J., Delius M., Brendel W. A retrospective analysis of 3 year's experience of an interdisciplinary approach to gallstone disease including shock-waves. Ann Surg. 1988 Sep;208(3):274–278. doi: 10.1097/00000658-198809000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. IWATA T., YAMASAKI K. ENZYMATIC DETERMINATION AND THIN-LAYER CHROMATOGRAPHY OF BILE ACIDS IN BLOOD. J Biochem. 1964 Nov;56:424–431. doi: 10.1093/oxfordjournals.jbchem.a128013. [DOI] [PubMed] [Google Scholar]
  13. Krukemyer J. J., Talbert R. L. Lovastatin: a new cholesterol-lowering agent. Pharmacotherapy. 1987;7(6):198–210. doi: 10.1002/j.1875-9114.1987.tb03524.x. [DOI] [PubMed] [Google Scholar]
  14. Logan G. M., Duane W. C. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation. Gastroenterology. 1990 Jun;98(6):1572–1576. doi: 10.1016/0016-5085(90)91092-k. [DOI] [PubMed] [Google Scholar]
  15. Pertsemlidis D., Panveliwalla D., Ahrens E. H., Jr Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology. 1974 Apr;66(4):565–573. [PubMed] [Google Scholar]
  16. Roda E., Bazzoli F., Labate A. M., Mazzella G., Roda A., Sama C., Festi D., Aldini R., Taroni F., Barbara L. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology. 1982 Nov-Dec;2(6):804–810. doi: 10.1002/hep.1840020611. [DOI] [PubMed] [Google Scholar]
  17. Sackmann M., Delius M., Sauerbruch T., Holl J., Weber W., Ippisch E., Hagelauer U., Wess O., Hepp W., Brendel W. Shock-wave lithotripsy of gallbladder stones. The first 175 patients. N Engl J Med. 1988 Feb 18;318(7):393–397. doi: 10.1056/NEJM198802183180701. [DOI] [PubMed] [Google Scholar]
  18. Salen G., Colalillo A., Verga D., Bagan E., Tint G. S., Shefer S. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans. Gastroenterology. 1980 Jun;78(6):1412–1418. [PubMed] [Google Scholar]
  19. Schoenfield L. J., Lachin J. M. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med. 1981 Sep;95(3):257–282. doi: 10.7326/0003-4819-95-3-257. [DOI] [PubMed] [Google Scholar]
  20. Stone B. G., Erickson S. K., Craig W. Y., Cooper A. D. Regulation of rat biliary cholesterol secretion by agents that alter intrahepatic cholesterol metabolism. Evidence for a distinct biliary precursor pool. J Clin Invest. 1985 Nov;76(5):1773–1781. doi: 10.1172/JCI112168. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES